Study shows missed opportunities for HIV diagnosis in emergency departments

July 29, 2011 in HIV & AIDS

New University of Cincinnati (UC) research on HIV testing at local emergency departments shows that hospitals miss opportunities to diagnose patients who do not know they are infected with HIV, even when a regular testing program is in place.

The study is part of a special supplement to the July issue of , sponsored by the (CDC). The supplement includes a series of studies on HIV testing in the nation's emergency departments, finding that while a growing number of emergency departments (EDs) are providing some HIV testing, there are still challenges to widespread expansion of testing as a routine part of emergency care.

UC Assistant Professor of emergency medicine Michael Lyons, MD, was one of four guest editors for the publication.

"HIV testing in is one of the most critical parts of the fight against HIV," says Lyons, lead author on the study. "Previous studies have shown that patients with undiagnosed HIV often visit health care settings, particularly emergency departments, before eventually receiving a diagnosis, but how to capitalize on these opportunities for earlier diagnosis remains unclear. We also do not fully understand how the frequency of missed opportunities differs between different emergency departments."

The study reviewed records for a set of 276 newly diagnosed to determine whether the diagnosis might have been made in an earlier ED visit that didn't include an HIV test. Researchers found missed opportunities occurred in 157 visits to an academic emergency department, 24 visits in an urban community hospital and six visits to a suburban community hospital.

"The number of missed opportunities differed between facilities, but all centers had at least some encounters with persons with undiagnosed HIV," says Christopher Lindsell, PhD, co-author and vice chair for research in emergency medicine at UC.

"Many, but not all, encounters included at least one indication for HIV testing. This suggests that only universal screening will identify all undiagnosed patients—but when that's not feasible, physicians can improve overall detection by testing patients who they recognize as having increased risk of infection. All EDs should be capable of HIV testing in these instances."

A related study by Lindsell, also in the CDC supplement, described a method for hospitals to estimate the number of patients with undiagnosed HIV that visit their ED. "We know that not all EDs see the same number of undiagnosed patients. With this tool, an ED can estimate their need for screening before investing significant resources to increase testing," says Lindsell.

Several other UC studies, led by emergency medicine and infectious diseases researchers, are also included in the supplement, all designed to better understand how to expand HIV testing and prevention in emergency department settings.

"With this research, the academic emergency medicine community is helping to interpret and implement the CDC's recommendations for routine screening in health care settings," says Lyons. "Altogether there has been a lot of progress; there are still many challenges to expanding HIV testing. We're trying to provide a road map to show where and how limited testing resources are best allocated and trying to motivate screening uptake by emergency physicians."

One UC study, led by former resident Nathan Hudepohl, MD, measured the number of patient visits and in the UC Health University Hospital ED from 2003 through 2008.

They found that although the HIV testing program provided testing during fewer than 2 percent of ED visits each year, the number of ED patients who had been tested by the program eventually grew to 6.9 percent.

"In just five years of testing, we increased the proportion of ED patients known to have been tested in the program 18 percent," says Lyons.

"Although this falls short of the universal testing advocated by the CDC, our results show that incremental efforts can gradually accumulate impact over time. Even if an ED cannot test as frequently as is recommended, the ED can still work towards screening the population by providing whatever amount of testing is possible."

Provided by University of Cincinnati Academic Health Center

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Mortality rates decrease, chronic disease rates increase among HIV+ ICU patients

The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) ...

HIV & AIDS created May 23, 2012 | popularity not rated yet | comments 0

Newly discovered breast milk antibodies help neutralize HIV

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (3) | comments 1 | with audio podcast

Reactions to HIV drug have autoimmune cause, reports AIDS journal

Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (1) | comments 0

Is the U.S. ready for home HIV tests?

At the pharmacy, you can buy anything from tea kettles to Tylenol. But what if you could buy a rapid HIV test over the counter and test yourself in the privacy of your own home?

HIV & AIDS created May 21, 2012 | popularity not rated yet | comments 0 | with audio podcast

Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use

A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...

HIV & AIDS created May 17, 2012 | popularity 5 / 5 (1) | comments 0


Pancreatectomy OK without downstaging from therapy

(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...

Flesh-Eating bacteria no cause for panic, experts say

(HealthDay) -- Despite scary headlines by the score, most people don't have to fear that they'll be the next victim of the so-called flesh-eating bacteria disease, experts say.

Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Inherited DNA change explains overactive leukemia gene

A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

New device allows pacemaker patients to safely undergo MRIs

For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.